Sara A Hurvitz Selected Research

Sara A Hurvitz Research Topics

Disease

84	Breast Neoplasms (Breast Cancer) 01/2022 - 11/2008
37	Neoplasms (Cancer) 01/2022 - 09/2005
12	Disease Progression 01/2022 - 06/2005
10	Triple Negative Breast Neoplasms 09/2022 - 01/2018
9	Neoplasm Metastasis (Metastasis) 09/2022 - 04/2012
8	Fatigue 07/2021 - 10/2009
6	Diarrhea 01/2021 - 10/2009
6	Neutropenia 01/2021 - 10/2009
5	Brain Neoplasms (Brain Tumor) 06/2022 - 03/2014
4	Cardiotoxicity 01/2022 - 01/2014
4	Anemia 01/2021 - 01/2018
4	B-Cell Lymphoma (Lymphoma, B Cell) 09/2012 - 09/2005
4	Lymphoma (Lymphomas) 09/2012 - 06/2005
3	Pneumonia (Pneumonitis) 01/2022 - 10/2013
3	Nausea 02/2020 - 01/2020
3	Alopecia (Baldness) 02/2020 - 07/2015
3	Stomatitis 01/2020 - 10/2013
3	Pathologic Complete Response 01/2020 - 09/2018
3	Vomiting 01/2020 - 10/2013
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2009 - 06/2005
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 01/2020
2	Body Weight (Weight, Body) 06/2021 - 01/2020
2	Febrile Neutropenia 01/2021 - 01/2018
2	Central Nervous System Diseases (CNS Diseases) 01/2020 - 03/2014
2	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 10/2009
2	Thrombocytopenia (Thrombopenia) 01/2014 - 10/2009
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Constipation 07/2021
1	Overweight 06/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021

Drug/Important Bio-Agent (IBA)

28	Trastuzumab (Herceptin)FDA Link 01/2022 - 12/2010
25	Hormones (Hormone)IBA 09/2022 - 11/2008
17	human ERBB2 proteinIBA 01/2022 - 12/2010
14	Ado-Trastuzumab EmtansineIBA 01/2022 - 09/2012
13	Capecitabine (Xeloda)FDA Link 11/2021 - 03/2013
13	Lapatinib (GW572016)FDA Link 11/2021 - 04/2012
10	ErbB Receptors (EGF Receptor)IBA 01/2022 - 03/2013
8	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 09/2012
7	Estrogen ReceptorsIBA 01/2022 - 11/2008
7	Docetaxel (Taxotere)FDA Link 12/2021 - 08/2010
7	Proteins (Proteins, Gene)FDA Link 11/2021 - 09/2005
7	Everolimus FDA Link 01/2021 - 12/2010
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2013
6	pertuzumabIBA 12/2021 - 12/2014
6	Paclitaxel (Taxol)FDA LinkGeneric 09/2018 - 08/2010
5	sacituzumab govitecanIBA 09/2022 - 01/2021
5	Cyclin-Dependent Kinase 4IBA 01/2022 - 01/2021
5	talazoparibIBA 01/2022 - 01/2018
4	taxaneIBA 01/2022 - 10/2013
4	AnthracyclinesIBA 01/2022 - 01/2016
4	Vinorelbine (Navelbine)FDA LinkGeneric 01/2021 - 01/2016
4	Gemcitabine FDA Link 01/2021 - 01/2016
3	Pharmaceutical PreparationsIBA 01/2022 - 01/2020
3	Aromatase InhibitorsIBA 01/2022 - 11/2008
3	palbociclibIBA 01/2022 - 01/2021
3	Letrozole (Femara)FDA LinkGeneric 01/2022 - 01/2018
3	Carboplatin (JM8)FDA LinkGeneric 12/2021 - 01/2018
3	neratinibIBA 11/2021 - 01/2020
3	eribulin FDA Link 01/2021 - 01/2018
3	ribociclibIBA 01/2021 - 01/2018
3	Transaminases (Aminotransferases)IBA 01/2020 - 01/2014
3	Monoclonal AntibodiesIBA 12/2019 - 10/2009
3	Bevacizumab (Avastin)FDA Link 06/2015 - 08/2010
3	TOR Serine-Threonine KinasesIBA 03/2014 - 12/2010
3	VaccinesIBA 09/2008 - 06/2005
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 01/2018
2	trastuzumab deruxtecanIBA 01/2022 - 01/2020
2	exemestane (Aromasin)FDA Link 01/2021 - 02/2015
2	Fulvestrant (Faslodex)FDA Link 01/2021 - 02/2015
2	Epidermal Growth Factor (EGF)IBA 06/2020 - 04/2012
2	Poly Adenosine Diphosphate RiboseIBA 02/2020 - 01/2018
2	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 01/2020 - 09/2008
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 05/2013
2	Biological ProductsIBA 01/2020 - 07/2015
2	PlatinumIBA 01/2019 - 01/2018
2	Cytotoxins (Cytolysins)IBA 01/2018 - 03/2013
2	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2018 - 03/2014
2	Angiogenesis InhibitorsIBA 01/2018 - 08/2010
2	Progesterone Receptors (Progesterone Receptor)IBA 09/2015 - 09/2009
2	benthiocarb (Bolero)IBA 07/2015 - 07/2014
2	Tamoxifen FDA LinkGeneric 02/2015 - 11/2008
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 03/2014 - 03/2014
2	Rituximab (Mabthera)FDA Link 09/2012 - 06/2005
2	Neoplasm Antigens (Tumor Antigens)IBA 09/2008 - 09/2005
1	Codon (Codons)IBA 01/2022
1	AntibodiesIBA 01/2022
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Surface Antigens (Surface Antigen)IBA 01/2021
1	Topoisomerase I InhibitorsIBA 01/2021

Therapy/Procedure

53	Therapeutics 06/2022 - 11/2008
22	Drug Therapy (Chemotherapy) 01/2022 - 09/2009
5	Aftercare (After-Treatment) 01/2022 - 01/2018
4	Neoadjuvant Therapy 01/2021 - 01/2017
4	Radiotherapy 01/2021 - 10/2015
3	Adjuvant Chemotherapy 06/2022 - 01/2017
3	Immunotherapy 01/2018 - 06/2005
3	Mastectomy (Mammectomy) 01/2018 - 10/2015
1	Palliative Care (Palliative Therapy) 01/2022